Atlas FDA

EUFLEXXA (1% SODIUM HYALURONATE)

FDA premarket approval P010029/S013 · decided 2012-01-27

Approval details

PMA number
P010029
Supplement
S013
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
EUFLEXXA (1% SODIUM HYALURONATE)
Generic name
Acid, hyaluronic, intraarticular
Applicant
Ferring Pharmaceuticals, Inc.
Date received
2011-12-29
Decision date
2012-01-27
Days to decision
29 days
Decision code
OK30
Product code
MOZ
Advisory committee
Orthopedic
Expedited review
No
Location
Parsippany, NJ
Statement
NEW VISCOMETER, FOR THE IN-PROCESS AND QUALITY CONTROL RELEASE TESTING.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.